| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.55 | 0.004 | 0.55 | 5-Lipoxygenase inhibitor | |||
| 0.531 | 0.015 | 0.531 | Lipoxygenase inhibitor | 0.186 0.155 CID_154699833 0.232 0.113 CID_154699502 | ||
| 0.511 | 0.011 | 0.613 | Vasodilator | 0.254 0.067 CID_154699833 0.613 0.005 CID_154699502 | CID_154699502 | |
| 0.499 | 0.041 | 0.607 | Antibacterial | 0.607 0.018 CID_154699833 0.499 0.041 CID_154699502 | CID_154699833 | |
| 0.428 | 0.095 | 0.428 | Caspase 9 stimulant | 0.413 0.103 CID_154699502 | ||
| 0.327 | 0.017 | 0.327 | Peptidyltransferase inhibitor | 0.299 0.025 CID_154699833 0.314 0.02 CID_154699502 | ||
| 0.369 | 0.069 | 0.369 | Thioredoxin glutathione reductase inhibitor | |||
| 0.393 | 0.143 | 0.393 | Antiinflammatory | 0.277 0.237 CID_154699833 | ||
| 0.256 | 0.062 | 0.256 | Tyrosine 3 hydroxylase inhibitor | 0.199 0.138 CID_154699502 | ||
| 0.192 | 0.044 | 0.194 | NOS3 expression enhancer | 0.194 0.043 CID_154699833 0.154 0.069 CID_154699502 | CID_154699833 | |
| 0.177 | 0.042 | 0.289 | Cell wall synthesis inhibitor | 0.289 0.01 CID_154699833 0.134 0.081 CID_154699502 | CID_154699833 | |
| 0.164 | 0.036 | 0.164 | Topoisomerase I inhibitor | 0.137 0.047 CID_154699833 0.145 0.043 CID_154699502 | ||
| 0.169 | 0.045 | 0.169 | Alpha-N-acetylglucosaminidase inhibitor | 0.101 0.1 CID_154699833 0.163 0.048 CID_154699502 | ||
| 0.221 | 0.102 | 0.229 | Interleukin agonist | 0.229 0.095 CID_154699502 | CID_154699502 | |
| 0.12 | 0.004 | 0.12 | Aggrecanase 1 inhibitor | |||
| 0.169 | 0.056 | 0.169 | Heat shock protein 90 antagonist | |||
| 0.191 | 0.08 | 0.191 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.179 0.094 CID_154699502 | ||
| 0.153 | 0.048 | 0.153 | Topoisomerase II inhibitor | 0.13 0.06 CID_154699833 0.127 0.062 CID_154699502 | ||
| 0.204 | 0.106 | 0.204 | Tumour necrosis factor alpha release inhibitor | |||
| 0.145 | 0.057 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 CID_154699502 | CID_154699502 | |
| 0.159 | 0.078 | 0.159 | Heat shock protein 90 alpha antagonist | |||
| 0.161 | 0.087 | 0.229 | Phospholipase C inhibitor | 0.229 0.03 CID_154699833 | CID_154699833 | |
| 0.096 | 0.028 | 0.096 | Leukotriene synthesis inhibitor | |||
| 0.079 | 0.012 | 0.083 | Farnesyltransferase inhibitor | 0.075 0.014 CID_154699833 0.083 0.011 CID_154699502 | CID_154699502 | |
| 0.123 | 0.056 | 0.141 | Cystathionine beta-synthase inhibitor | 0.141 0.045 CID_154699502 | CID_154699502 | |
| 0.095 | 0.031 | 0.1 | GABA aminotransferase inhibitor | 0.1 0.027 CID_154699502 | CID_154699502 | |
| 0.141 | 0.078 | 0.141 | Cyclooxygenase inhibitor | |||
| 0.091 | 0.033 | 0.236 | CDC25A inhibitor | 0.236 0.005 CID_154699833 0.094 0.031 CID_154699502 | CID_154699833 | |
| 0.129 | 0.072 | 0.129 | Cyclooxygenase 1 inhibitor | |||
| 0.092 | 0.038 | 0.092 | Telomerase inhibitor | 0.088 0.04 CID_154699502 | ||
| 0.096 | 0.059 | 0.096 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.093 0.062 CID_154699502 | ||
| 0.117 | 0.083 | 0.117 | Cyclooxygenase 2 inhibitor | |||
| 0.196 | 0.163 | 0.196 | Insulysin inhibitor | |||
| 0.096 | 0.066 | 0.096 | UDP-glucose 4-epimerase inhibitor | |||
| 0.104 | 0.074 | 0.104 | Electron transport complex I inhibitor | |||
| 0.084 | 0.054 | 0.095 | Antineoplastic antibiotic | 0.093 0.049 CID_154699833 0.095 0.049 CID_154699502 | CID_154699502 | |
| 0.246 | 0.219 | 0.246 | Apoptosis agonist | |||
| 0.088 | 0.063 | 0.088 | Potassium channel activator | |||
| 0.18 | 0.154 | 0.19 | DNA synthesis inhibitor | 0.19 0.138 CID_154699502 | CID_154699502 | |
| 0.132 | 0.108 | 0.132 | Heat shock protein 70 antagonist | |||
| 0.033 | 0.009 | 0.033 | Aggrecanase 2 inhibitor | |||
| 0.25 | 0.227 | 0.282 | 5 Hydroxytryptamine release inhibitor | 0.282 0.187 CID_154699502 | CID_154699502 | |
| 0.139 | 0.123 | 0.139 | Lipocortins synthesis antagonist | |||
| 0.073 | 0.058 | 0.129 | Analgesic, opioid | 0.129 0.019 CID_154699502 | CID_154699502 | |
| 0.018 | 0.005 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.178 | 0.167 | 0.178 | Transcription factor STAT3 inhibitor | |||
| 0.188 | 0.178 | 0.203 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.146 CID_154699502 | CID_154699502 | |
| 0.089 | 0.08 | 0.13 | Anabolic | 0.13 0.031 CID_154699833 0.102 0.059 CID_154699502 | CID_154699833 | |
| 0.188 | 0.181 | 0.289 | Transcription factor NF kappa B inhibitor | 0.223 0.148 CID_154699833 0.289 0.101 CID_154699502 | CID_154699502 | |
| 0.015 | 0.01 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.093 | 0.089 | 0.093 | GABA C receptor antagonist | |||
| 0.111 | 0.11 | 0.111 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.206 | 0.206 | 0.222 | 15-Lipoxygenase inhibitor | 0.222 0.189 CID_154699833 | CID_154699833 | |
| 0.06 | 0.069 | 0.066 | Glutamate (mGluR6) antagonist | 0.066 0.05 CID_154699502 | CID_154699502 | |
| 0.076 | 0.085 | 0.111 | Triose-phosphate isomerase inhibitor | 0.111 0.038 CID_154699833 | CID_154699833 | |
| 0.192 | 0.205 | 0.234 | Immunosuppressant | 0.234 0.162 CID_154699502 | CID_154699502 | |
| 0.074 | 0.088 | 0.121 | Aminopeptidase B inhibitor | 0.121 0.052 CID_154699833 | CID_154699833 | |
| 0.143 | 0.161 | 0.25 | Immunostimulant | 0.25 0.096 CID_154699833 | CID_154699833 | |
| 0.193 | 0.217 | 0.225 | GABA C receptor rho-3 antagonist | 0.225 0.179 CID_154699502 | CID_154699502 | |
| 0.064 | 0.089 | 0.106 | Glycine receptor antagonist | 0.106 0.027 CID_154699833 | CID_154699833 | |
| 0.089 | 0.117 | 0.145 | Acetylcholine release stimulant | 0.145 0.02 CID_154699833 0.097 0.095 CID_154699502 | CID_154699833 | |
| 0.189 | 0.216 | 0.37 | Histamine release inhibitor | 0.37 0.091 CID_154699833 0.202 0.199 CID_154699502 | CID_154699833 | |
| 0.014 | 0.047 | 0.023 | Dopamine D1 agonist | 0.023 0.015 CID_154699833 | CID_154699833 | |
| 0.046 | 0.079 | 0.067 | NMDA receptor agonist | 0.067 0.038 CID_154699833 | CID_154699833 | |
| 0.047 | 0.092 | 0.063 | Protease 3C (Human rhinovirus) inhibitor | 0.063 0.047 CID_154699833 | CID_154699833 | |
| 0.132 | 0.19 | 0.272 | Antioxidant | 0.272 0.073 CID_154699833 | CID_154699833 | |
| 0.02 | 0.088 | 0.048 | Purinergic P2Y2 antagonist | 0.048 0.011 CID_154699833 | CID_154699833 | |
| 0.102 | 0.174 | 0.127 | Adenylate cyclase stimulant | 0.127 0.108 CID_154699833 | CID_154699833 | |
| 0.07 | 0.148 | 0.185 | Multidrug resistance-associated protein 1 inhibitor | 0.185 0.014 CID_154699833 | CID_154699833 | |
| 0.029 | 0.108 | 0.064 | Neuraminidase inhibitor | 0.064 0.039 CID_154699833 | CID_154699833 | |
| 0.141 | 0.224 | 0.242 | RNA-directed DNA polymerase inhibitor | 0.242 0.055 CID_154699833 | CID_154699833 | |
| 0.061 | 0.148 | 0.229 | Chelator | 0.229 0.019 CID_154699502 | CID_154699502 | |
| 0.037 | 0.127 | 0.076 | Neuraminidase (influenza) inhibitor | 0.076 0.029 CID_154699833 | CID_154699833 | |
| 0.031 | 0.139 | 0.097 | Catalase inhibitor | 0.097 0.04 CID_154699833 | CID_154699833 | |
| 0.104 | 0.225 | 0.278 | Spasmolytic | 0.278 0.079 CID_154699833 | CID_154699833 | |
| 0.007 | 0.146 | 0.021 | Glutamate (mGluR1a) agonist | 0.021 0.017 CID_154699833 | CID_154699833 | |
| 0.047 | 0.199 | 0.105 | Cholesterol synthesis inhibitor | 0.105 0.081 CID_154699833 | CID_154699833 | |
| 0.113 | 0.299 | 0.284 | Cholesterol antagonist | 0.284 0.101 CID_154699833 | CID_154699833 | |
| 0.098 | 0.304 | 0.239 | Superoxide dismutase inhibitor | 0.239 0.082 CID_154699833 | CID_154699833 | |
| 0.028 | 0.238 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 CID_154699833 | CID_154699833 | |
| 0.048 | 0.27 | 0.263 | Protein-tyrosine phosphatase inhibitor | 0.263 0.028 CID_154699833 | CID_154699833 | |
| 0.054 | 0.278 | 0.124 | Cholinergic | 0.124 0.102 CID_154699502 | CID_154699502 | |
| 0.049 | 0.292 | 0.348 | Angiogenesis stimulant | 0.348 0.033 CID_154699833 | CID_154699833 | |
| 0.013 | 0.278 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.067 0.041 CID_154699833 | CID_154699833 | |
| 0.013 | 0.287 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.018 CID_154699833 | CID_154699833 | |
| 0.009 | 0.285 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.036 CID_154699833 | CID_154699833 | |
| 0.009 | 0.318 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.04 CID_154699833 | CID_154699833 | |
| 0.01 | 0.347 | 0.098 | Selectin antagonist | 0.098 0.028 CID_154699833 | CID_154699833 | |
| 0.081 | 0.457 | 0.209 | Sodium/bile acid cotransporter inhibitor | 0.209 0.176 CID_154699833 | CID_154699833 | |
| 0.021 | 0.452 | 0.392 | Diuretic | 0.392 0.013 CID_154699833 | CID_154699833 | |
| 0.01 | 0.541 | 0.223 | Cholecystokinin B agonist | 0.223 0.004 CID_154699833 | CID_154699833 | |
| 0.02 | 0.578 | 0.337 | Dual specificity phosphatase inhibitor | 0.337 0.023 CID_154699833 | CID_154699833 | |
| 0.007 | 0.585 | 0.049 | Protein kinase C eta inhibitor | 0.049 0.045 CID_154699502 | CID_154699502 | |
| 0.025 | 0.637 | 0.137 | Platelet adhesion inhibitor | 0.137 0.122 CID_154699833 | CID_154699833 | |
| 0.005 | 0.633 | 0.028 | NMDA 2D receptor antagonist | 0.028 0.018 CID_154699833 | CID_154699833 | |
| 0.004 | 0.661 | 0.106 | NMDA 2B receptor antagonist | 0.106 0.014 CID_154699833 | CID_154699833 | |
| 0.023 | 0.685 | 0.16 | Aurora-C kinase inhibitor | 0.16 0.039 CID_154699502 | CID_154699502 | |
| 0.002 | 0.792 | 0.104 | Cholecystokinin agonist | 0.104 0.004 CID_154699833 | CID_154699833 | |
| 0.003 | 0.794 | 0.035 | Cholecystokinin A antagonist | 0.035 0.028 CID_154699833 | CID_154699833 | |
| 0.003 | 0.8 | 0.101 | Cholecystokinin A agonist | 0.101 0.004 CID_154699833 | CID_154699833 | |
| 0.007 | 0.823 | 0.11 | Protein kinase C mu inhibitor | 0.11 0.049 CID_154699502 | CID_154699502 | |
| 0.005 | 0.871 | 0.147 | Anticoagulant | 0.147 0.083 CID_154699833 | CID_154699833 | |
| 0.005 | 0.899 | 0.217 | Dual specificity phosphatase 3 inhibitor | 0.217 0.052 CID_154699833 | CID_154699833 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |